Our analysis of prognostic value of PD-L1 expression in consecutive homogenous group of 117 patients with stage III unresectable NSCLC, treated with combination of ChT and RT is the largest one published until now. The gene discussed is CD274; the disease is non-small cell lung carcinoma.